|
Aderem, A. and D. M. Underhill (1999). "Mechanisms of phagocytosis in macrophages." Annual Review of Immunology 17(1): 593-623. Akira, S., et al. (2001). "Toll-like receptors: critical proteins linking innate and acquired immunity." Nature Immunology 2: 675. Alves, A. C., et al. (1996). "Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro." European journal of pharmacology 312(1): 89-96. Aronoff, D. M., et al. (2005). "Cutting edge: Macrophage inhibition by cyclic AMP (cAMP): Differential roles of protein kinase A and exchange protein directly activated by cAMP-1." The Journal of Immunology 174(2): 595. Aronoff, D. M., et al. (2006). "Short communication: Differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis." Journal of Interferon & Cytokine Research 26(11): 827-833. Asirvatham, A. L., et al. (2004). "A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines." The Journal of Immunology 173(8): 4806-4814. Banerjee, S., et al. (2015). "RNase L is a negative regulator of cell migration." Oncotarget 6(42): 44360-44372. Beard, M. B., et al. (2000). "UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions." Journal of Biological Chemistry 275(14): 10349-10358. Beavo, J. A. and L. L. Brunton (2002). "Cyclic nucleotide research—still expanding after half a century." Nature reviews Molecular cell biology 3(9): 710. Bhushan, S., et al. (2009). "Testicular innate immune defense against bacteria." Molecular and Cellular Endocrinology 306(1): 37-44. Bos, J. L. (2006). "Epac proteins: multi-purpose cAMP targets." Trends in biochemical sciences 31(12): 680-686. Brand, T. and R. Schindler (2017). "New kids on the block: The popeye domain containing (Popdc) protein family acting as a novel class of cAMP effector proteins in striated muscle." Cellular signalling 40: 156-165. Brink, H. E., et al. (2006). "Serum-dependent effects on adult and fetal tendon fibroblast migration and collagen expression." Wound Repair and Regeneration 14(2): 179-186. Burdyga, A., et al. (2013). "cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC." Biochimica et biophysica acta 1833(12): 2664-2672. Cedervall, P., et al. (2015). "Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4." Proceedings of the National Academy of Sciences: 201419906. Chen, L., et al. (2008). "cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation." Journal of Biological Chemistry 283(20): 13799-13805. CHIN, K. V., et al. (2002). "Reinventing the wheel of cyclic AMP." Annals of the New York Academy of Sciences 968(1): 49-64. Chung, K. F. (2006). "Phosphodiesterase inhibitors in airways disease." European journal of pharmacology 533(1-3): 110-117. Conti, M. and J. Beavo (2007). "Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling." Annu. Rev. Biochem. 76: 481-511. Daley, J. M., et al. (2010). "The phenotype of murine wound macrophages." Journal of leukocyte biology 87(1): 59-67. de Rooij, J., et al. (1998). "Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP." Nature 396: 474. Dell’Acqua, M. L. and J. D. Scott (1997). "Protein kinase A anchoring." Journal of Biological Chemistry 272(20): 12881-12884. Etxebarria, J., et al. (2017). "Serum from plasma rich in growth factors regenerates rabbit corneas by promoting cell proliferation, migration, differentiation, adhesion and limbal stemness." Acta Ophthalmologica 95(8): e693-e705. Fleming, Y. M., et al. (2004). "PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration." Journal of Cell Science 117(11): 2377. Fukata, M., et al. (2009). "Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors." Inflammatory bowel diseases 15(7): 997-1006. Furundzija, V., et al. (2010). "IGF-1 increases macrophage motility via PKC/p38-dependent αvβ3-integrin inside-out signaling." Biochemical and Biophysical Research Communications 394(3): 786-791. Gentek, R., et al. (2014). "Tissue macrophage identity and self‐renewal." Immunological reviews 262(1): 56-73. Gloerich, M. and J. L. Bos (2010). "Epac: defining a new mechanism for cAMP action." Annual review of pharmacology toxicology 50: 355-375. Goc, A., et al. (2010). "Structural characterization of the rod cGMP phosphodiesterase 6." Journal of molecular biology 401(3): 363-373. Grandoch, M., et al. (2009). "Epac inhibits migration and proliferation of human prostate carcinoma cells." British journal of cancer 101(12): 2038-2042. Gregory, S. H., et al. (2002). "Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver." The Journal of Immunology 168(1): 308-315. Hesketh, M., et al. (2017). "Macrophage phenotypes regulate scar formation and chronic wound healing." International journal of molecular sciences 18(7): 1545. Hu, X., et al. (2008). "Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms." Immunological reviews 226(1): 41-56. Imhof, B. A. and M. Aurrand-Lions (2004). "Adhesion mechanisms regulating the migration of monocytes." Nature Reviews Immunology 4(6): 432. Jin, S., et al. (2012). "Phosphodiesterase 4 and its inhibitors in inflammatory diseases." Chang Gung Med J 35(3): 197-210. Jin, S.-L., et al. (1992). "Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain." Journal of Biological Chemistry 267(26): 18929-18939. Jin, S.-L. C., et al. (2005). "Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages." The Journal of Immunology 175(3): 1523-1531. Junt, T., et al. (2007). "Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells." Nature 450(7166): 110. Kaufman, L. M. and J. N. Barrett (1983). "Serum factor supporting long-term survival of rat central neurons in culture." Science 220(4604): 1394. Kaupp, U. B. and R. Seifert (2002). "Cyclic nucleotide-gated ion channels." Physiological reviews 82(3): 769-824. Kawai, T. and S. Akira (2010). "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors." Nature Immunology 11: 373. Kawasaki, H., et al. (1998). "A family of cAMP-binding proteins that directly activate Rap1." Science 282(5397): 2275-2279. Kim, J.-S., et al. (2006). "Transforming growth factor-β1 regulates macrophage migration via RhoA." Blood 108(6): 1821. Kim, M. O., et al. (2015). "cAMP promotes cell migration through cell junctional complex dynamics and actin cytoskeleton remodeling: Implications in skin wound healing." Stem cells development 24(21): 2513-2524. Kim, S.-Y., et al. (2010). "Role of NADPH oxidase-2 in lipopolysaccharide-induced matrix metalloproteinase expression and cell migration." Immunology & Cell Biology 88(2): 197-204. Kohyama, T., et al. (2004). "Cytokines modulate cilomilast response in lung fibroblasts." Clinical Immunology 111(3): 297-302. Kopydlowski, K. M., et al. (1999). "Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo." The Journal of Immunology 163(3): 1537. Krähling, A. M., et al. (2013). "CRIS—a novel cAMP-binding protein controlling spermiogenesis and the development of flagellar bending." PLoS genetics 9(12): e1003960. Krettek, A., et al. (2001). "Expression of PDGF receptors and ligand-induced migration of partially differentiated human monocyte-derived macrophages: Influence of IFN-γ and TGF-β." Atherosclerosis 156(2): 267-275. Kumar, N., et al. (2013). "Phosphodiesterase 4-targeted treatments for autoimmune diseases." BMC medicine 11: 96-96. Lai, C.-R., et al. (2015). "Phosphodiesterase 4B is essential for lipopolysaccharide-induced CC chemokine ligand 3 production in mouse macrophages." Journal of Medical Sciences 35(3): 111-119. Lauffenburger, D. A. and A. F. Horwitz (1996). "Cell migration: a physically integrated molecular process." cell 84(3): 359-369. Layseca-Espinosa, E., et al. (2003). "Rolipram Inhibits polarization and migration of human T lymphocytes." Journal of Investigative Dermatology 121(1): 81-87. LENHARD, J. M., et al. (1996). "Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase." Biochemical Journal 316(3): 751-758. Lichtman, S. N., et al. (1998). "LPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cells." American Journal of Physiology-Gastrointestinal and Liver Physiology 275(1): G39-G46. Lorenowicz, M. J., et al. (2008). "PKA and Epac1 regulate endothelial integrity and migration through parallel and independent pathways." European journal of cell biology 87(10): 779-792. Martinez, S. E., et al. (2002). "The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding." Proceedings of the National Academy of Sciences 99(20): 13260-13265. Matthiesen, K. and J. Nielsen (2009). "Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity." Biochemical Journal 423(3): 401-409. Maurice, D. H., et al. (2014). "Advances in targeting cyclic nucleotide phosphodiesterases." Nature reviews. Drug discovery 13(4): 290-314. McKean, J. S., et al. (2015). "The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP." Cardiovascular research 107(4): 546-555. Mebius, R. E. and G. Kraal (2005). "Structure and function of the spleen." Nature Reviews Immunology 5(8): 606. Michaud, J., et al. (2010). "Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation." Journal of immunology (Baltimore, Md. : 1950) 184(3): 1475-1483. Moon, M.-Y., et al. (2013). "Small GTPase Rap1 regulates cell migration through regulation of small GTPase RhoA activity in response to transforming growth factor-β1." Journal of Cellular Physiology 228(11): 2119-2126. Mou, H. and R. H. Cote (2001). "The catalytic and GAF domains of the rod cGMP phosphodiesterase (PDE6) heterodimer are regulated by distinct regions of its inhibitory γ subunit." Journal of Biological Chemistry 276(29): 27527-27534. Muradov, H., et al. (2004). "Structural determinants of the PDE6 GAF A domain for binding the inhibitory γ-subunit and noncatalytic cGMP." Vision research 44(21): 2437-2444. Murray, M. Y., et al. (2013). "Macrophage migration and invasion is regulated by MMP10 expression." PloS one 8(5): e63555-e63555. Murray, P. J. and T. A. Wynn (2011). "Protective and pathogenic functions of macrophage subsets." Nature Reviews Immunology 11(11): 723. Netherton, S. J. and D. H. Maurice (2005). "Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: Implications in angiogenesis." Molecular Pharmacology 67(1): 263. Ohto, U., et al. (2007). "Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa." Science 316(5831): 1632. Omori, K. and J. Kotera (2007). "Overview of PDEs and their regulation." Circulation research 100(3): 309-327. Panzer, U. and M. Uguccioni (2004). "Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines." European journal of immunology 34(12): 3682-3689. Petrie, R. J., et al. (2009). "Random versus directionally persistent cell migration." Nature reviews Molecular cell biology 10: 538. Pollard, J. W. (2009). "Trophic macrophages in development and disease." Nature reviews. Immunology 9(4): 259-270. Poole, N. M., et al. (2013). "Prostaglandin E(2) in tick saliva regulates macrophage cell migration and cytokine profile." Parasites & vectors 6(1): 261-261. Porpodis, K., et al. (2015). "Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients." International journal of chronic obstructive pulmonary disease 10: 1123-1128. Prabhakar, U., et al. (1994). "Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor." International Journal of Immunopharmacology 16(10): 805-816. Richter, W. and M. Conti (2002). "Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs)." Journal of Biological Chemistry. Ridley, A. J. (2001). "Rho proteins, PI 3‐kinases, and monocyte/macrophage motility." FEBS letters 498(2-3): 168-171. Ridley, A. J., et al. (2003). "Cell migration: integrating signals from front to back." Science 302(5651): 1704-1709. Ring, S., et al. (2015). "Regulatory T cell–derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway." The Journal of Immunology 194(8): 3735. Rybalkin, S. D., et al. (2003). "PDE5 is converted to an activated state upon cGMP binding to the GAF A domain." The EMBO Journal 22(3): 469-478. Sandulache, V. C., et al. (2007). "Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-β1–induced collagen synthesis." Wound Repair and Regeneration 15(1): 122-133. Santamaria, L. F., et al. (1997). "Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram." British journal of pharmacology 121(6): 1150-1154. Schafer, P. H., et al. (2016). "Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex." Cellular signalling 28(7): 753-763. Schudt, C., et al. (1995). "PDE isoenzymes as targets for anti-asthma drugs." European Respiratory Journal 8(7): 1179-1183. Schumann, R. R., et al. (1990). "Structure and function of lipopolysaccharide binding protein." Science 249(4975): 1429. Serezani, C. H., et al. (2008). "Cyclic AMP: master regulator of innate immune cell function." American journal of respiratory cell and molecular biology 39(2): 127-132. Sette, C. and M. Conti (1996). "Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase involvement of serine 54 in the enzyme activation." Journal of Biological Chemistry 271(28): 16526-16534. Shabb, J. B. (2001). "Physiological substrates of cAMP-dependent protein kinase." Chemical reviews 101(8): 2381-2412. Shi, C. and E. G. Pamer (2011). "Monocyte recruitment during infection and inflammation." Nature Reviews Immunology 11(11): 762. Soderling, S. H., et al. (1999). "Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A." Proceedings of the National Academy of Sciences 96(12): 7071-7076. Tajima, T., et al. (2008). "Lipopolysaccharide induces macrophage migration via prostaglandin D2 and prostaglandin E2." Journal of Pharmacology Experimental Therapeutics 326(2): 493-501. Unanue, E. R. and P. M. Allen (1987). "The basis for the immunoregulatory role of macrophages and other accessory cells." Science 236(4801): 551-557. Veale, K. J., et al. (2010). "Recycling endosome membrane incorporation into the leading edge regulates lamellipodia formation and macrophage migration." Traffic 11(10): 1370-1379. Wang, J., et al. (2013). "Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1." Arthritis and rheumatism 65(3): 832-842. Wang, P., et al. (2003). "Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5): differential tissue distribution and subcellular localization of PDE9A variants." Gene 314: 15-27. Weeks, J. L., et al. (2007). "N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization." Biochemistry 46(36): 10353-10364. West, A. P., et al. (2006). "Recognition and signaling by Toll-like receptors." Annual Review of Cell and Developmental Biology 22(1): 409-437. Wright, S. D., et al. (1990). "CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein." Science 249(4975): 1431. Wu, P. and P. Wang (2004). "Per-Arnt-Sim domain-dependent association of cAMP-phosphodiesterase 8A1 with IκB proteins." Proceedings of the National Academy of Sciences of the United States of America 101(51): 17634-17639. Wynn, T. A., et al. (2013). "Macrophage biology in development, homeostasis and disease." Nature 496(7446): 445. Yang, J.-X., et al. (2017). "Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages." Scientific reports 7: 46165-46165. Yang, Y. H., et al. (2015). "Acetylcholine inhibits LPS-induced MMP-9 production and cell migration via the a7 nAChR-JAK2/STAT3 pathway in RAW264.7 cells." Cellular Physiology and Biochemistry 36(5): 2025-2038. Yokoyama, U., et al. (2008). "Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A." The Journal of biological chemistry 283(42): 28702-28709. Zhang, X. and D. Mosser (2008). "Macrophage activation by endogenous danger signals." The Journal of Pathology 214(2): 161-178. Zimmerman, N. P., et al. (2012). "Cyclic AMP dysregulates intestinal epithelial cell restitution through PKA and RhoA." Inflammatory bowel diseases 18(6): 1081-1091. Zoraghi, R., et al. (2004). "Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins." Molecular Pharmacology 65(2): 267-278.
|